Study on the Mechanism of Eerdun Wurile's Effects on Post-operative Cognitive Dysfunction by the TLR4/NF-κB Pathway

Yun Qiao1, Huiru Li1, Yan Li1

  • 1Department of Anesthesiology, The Affiliated Hospital of Inner Mongolia Medical University, Huimin District, Hohhot, 010059, Inner Mongolia Autonomous Region, China.

Molecular Neurobiology
|August 7, 2023
PubMed

Insights

The Mongolian medicine Eerdun Wurile (EW) effectively improves postoperative cognitive dysfunction (POCD) in mice. EW treatment suppresses the TLR4/NF-κB pathway and reduces inflammation, restoring cognitive function.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Postoperative cognitive dysfunction (POCD) is a common complication.
  • The TLR4/NF-κB pathway and neuroinflammation are implicated in POCD pathogenesis.

Purpose of the Study:

  • To investigate the therapeutic potential of Eerdun Wurile (EW) on POCD.
  • To elucidate the underlying mechanisms involving the TLR4/NF-κB pathway.

Main Methods:

  • A mouse model of POCD was established using intracerebroventricular lipopolysaccharide injection and nephrectomy.
  • Cognitive performance was assessed using the Morris water maze test.
  • Molecular analyses included immunohistochemistry, Western blotting, RT-qPCR, and ELISA to evaluate inflammatory markers and pathway activation.

Main Results:

  • POCD induction led to cognitive impairment, hippocampal alterations, and activation of the TLR4/NF-κB pathway and microglia.
  • EW treatment significantly improved cognitive performance in mice with POCD.
  • EW administration suppressed TLR4/NF-κB pathway activation, reduced microglial activation, and decreased pro-inflammatory cytokine (TNF-α, IL-1β, IL-6) levels.

Conclusions:

  • Eerdun Wurile (EW) demonstrates therapeutic efficacy in improving POCD in a mouse model.
  • The beneficial effects of EW are mediated, at least in part, by the modulation of the TLR4/NF-κB signaling pathway and reduction of neuroinflammation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K